Drug – bio-affecting and body treating compositions – Preparations characterized by special physical form – Tablets – lozenges – or pills
Reexamination Certificate
2006-11-14
2010-10-12
Richter, Johann R (Department: 1616)
Drug, bio-affecting and body treating compositions
Preparations characterized by special physical form
Tablets, lozenges, or pills
C424S489000, C514S220000
Reexamination Certificate
active
07811604
ABSTRACT:
The present invention is directed to non-effervescent, orally disintegrating dosage forms comprising free base clozapine that are substantially free of acids, water-soluble polymers, taste-masking polymers, and coatings, and methods of making and using the same.
REFERENCES:
patent: 4084000 (1978-04-01), Fuxe
patent: 4384005 (1983-05-01), McSweeney
patent: 4767789 (1988-08-01), Blank et al.
patent: 4832956 (1989-05-01), Gergely et al.
patent: 5071646 (1991-12-01), Malkowska et al.
patent: 5084278 (1992-01-01), Mehta
patent: 5112616 (1992-05-01), McCarty
patent: 5238688 (1993-08-01), Beuving et al.
patent: 5320848 (1994-06-01), Geyer et al.
patent: 5464632 (1995-11-01), Cousin et al.
patent: 5501861 (1996-03-01), Makino et al.
patent: 5576014 (1996-11-01), Mizumoto et al.
patent: 5587172 (1996-12-01), Cherukuri et al.
patent: 5587179 (1996-12-01), Gergely et al.
patent: 5587180 (1996-12-01), Allen et al.
patent: 5607697 (1997-03-01), Alkire et al.
patent: 5635210 (1997-06-01), Allen et al.
patent: 5725884 (1998-03-01), Sherwood et al.
patent: 5738875 (1998-04-01), Yarwood et al.
patent: 5776491 (1998-07-01), Allen et al.
patent: 5837285 (1998-11-01), Nakamichi et al.
patent: 5837292 (1998-11-01), Dijkgraaf et al.
patent: 5851553 (1998-12-01), Myers et al.
patent: 5866163 (1999-02-01), Myers et al.
patent: 5869098 (1999-02-01), Misra et al.
patent: 5871778 (1999-02-01), Kino et al.
patent: 5876759 (1999-03-01), Gowan
patent: 5939091 (1999-08-01), Eoga et al.
patent: 5955107 (1999-09-01), Augello et al.
patent: 5958453 (1999-09-01), Ohno et al.
patent: 6024981 (2000-02-01), Khankari et al.
patent: 6066337 (2000-05-01), Allen et al.
patent: 6083531 (2000-07-01), Humbert-Droz et al.
patent: 6106861 (2000-08-01), Chauveau et al.
patent: 6106865 (2000-08-01), Staniforth et al.
patent: 6149938 (2000-11-01), Bonadeo et al.
patent: 6156339 (2000-12-01), Grother et al.
patent: 6165512 (2000-12-01), Mezaache et al.
patent: 6177104 (2001-01-01), Allen et al.
patent: 6224909 (2001-05-01), Opitz et al.
patent: 6284270 (2001-09-01), Lagoviyer et al.
patent: 6316029 (2001-11-01), Jain et al.
patent: 6328994 (2001-12-01), Shimizu et al.
patent: 6368625 (2002-04-01), Siebert et al.
patent: 6375982 (2002-04-01), Cherukuri
patent: 6465009 (2002-10-01), Liu et al.
patent: 6465010 (2002-10-01), Lagoviyer et al.
patent: 6586004 (2003-07-01), Shimizu et al.
patent: 6589556 (2003-07-01), Cherukuri
patent: 6656492 (2003-12-01), Kajiyama et al.
patent: 6669957 (2003-12-01), Laruelle et al.
patent: 6680071 (2004-01-01), Johnson et al.
patent: 6723348 (2004-04-01), Faham et al.
patent: 6740339 (2004-05-01), Ohkouchi et al.
patent: 6740341 (2004-05-01), Holt et al.
patent: 7067116 (2006-06-01), Bess et al.
patent: 2001/0010825 (2001-08-01), Shimizu et al.
patent: 2002/0034540 (2002-03-01), Price
patent: 2002/0049233 (2002-04-01), Kararli et al.
patent: 2002/0071864 (2002-06-01), Kim et al.
patent: 2002/0160043 (2002-10-01), Coleman
patent: 2003/0017202 (2003-01-01), Bunick et al.
patent: 2003/0026835 (2003-02-01), Nishii et al.
patent: 2003/0035833 (2003-02-01), He
patent: 2003/0035839 (2003-02-01), Hirsh et al.
patent: 2003/0054038 (2003-03-01), Crew et al.
patent: 2003/0099701 (2003-05-01), Takaishi et al.
patent: 2003/0104063 (2003-06-01), Babcock et al.
patent: 2003/0104066 (2003-06-01), Murai et al.
patent: 2003/0124184 (2003-07-01), Mezaache et al.
patent: 2003/0147948 (2003-08-01), Shinoda et al.
patent: 2003/0165566 (2003-09-01), O'Toole et al.
patent: 2003/0170309 (2003-09-01), Babcock et al.
patent: 2003/0220413 (2003-11-01), Petereit et al.
patent: 2003/0229027 (2003-12-01), Eissens et al.
patent: 2004/0014680 (2004-01-01), Nakagami et al.
patent: 2004/0022849 (2004-02-01), Castan et al.
patent: 2004/0033258 (2004-02-01), Koike
patent: 2004/0037882 (2004-02-01), Johnson et al.
patent: 2004/0122106 (2004-06-01), Ohta et al.
patent: 2004/0253307 (2004-12-01), Hague et al.
patent: 2004/0265375 (2004-12-01), Platteeuw et al.
patent: 2005/0013857 (2005-01-01), Fu et al.
patent: 2005/0036977 (2005-02-01), Gole et al.
patent: 2005/0089568 (2005-04-01), Oshlack et al.
patent: 2005/0106240 (2005-05-01), Tanaka et al.
patent: 2005/0112196 (2005-05-01), Xie et al.
patent: 2005/0123609 (2005-06-01), Hirsh et al.
patent: 2005/0163830 (2005-07-01), Rademacher et al.
patent: 2005/0181050 (2005-08-01), Hirsh et al.
patent: 2005/0186284 (2005-08-01), Yang et al.
patent: 2005/0208127 (2005-09-01), Ogasawara et al.
patent: 2005/0208141 (2005-09-01), Farber et al.
patent: 2005/0232988 (2005-10-01), Venkatesh et al.
patent: 2005/0266088 (2005-12-01), Hinrichs et al.
patent: 200029224 (2000-09-01), None
patent: 1 161 941 (2001-12-01), None
patent: WO 87/05804 (1987-10-01), None
patent: WO 98/53798 (1998-12-01), None
patent: WO 99/43306 (1999-09-01), None
patent: WO 03/072084 (2003-09-01), None
patent: WO 03/103629 (2003-12-01), None
Bi, Y.X., et al., “Preparation and evaluation of a compressed tablet rapidly disintegrating in the oral Cavity,”Chem. Pharm. Bull. 44:2121-2127, Pharmaceutical Society of Japan (1996).
Bi, Y.X., et al., “Evaluation of rapidly disintegrating tablets prepared by a direct compression method,”Drug Dev. Ind. Pharm. 25:571-581, Marcel Dekker, Inc. (1999).
Bogner, R. and Wilkosz, M., “Fast-dissolving Tablets,”U.S. Pharmacist 27:34-43, Jobson Medical Information, LLC (2002) Accessed online: http://www.uspharmacist.com/oldformat.asp?url=newlook/files/feat/fastdissolving.htm, last.accessed Sep. 27, 2006.
Borsadia, S.B. et al., “Quick-dissolving films—a novel approach to drug delivery”Drug Delivery Tech. 3, Drug Delivery Technology (2003) Accessed online: http://www.drugdeliverytech.com/cgi-bin/articles.cgi?idArticle=138, last accessed Sep. 27, 2006.
Brown, D. “Orally disintegrating tablets—taste over speed,”Drug Delivery Tech. 3, Drug Delivery Technology (2003) Accessed online: http://www.drugdeliverytech.com/cgi-bin/articles.cgi?idArticle=164, last accessed Sep. 27, 2006.
Dobetti, L., “Fast-melting tablets: developments and technologies,”Pharm. Tech.: Drug Delivery 2001:44-50, Advanstar Communications, Inc. (2001) Accessed online: http://www.pharmtech.com/pharmtech/data/articlestandard/pharmtech/512001/5137/article.pdf, last accessed Sep. 27, 2006.
El-Arini, S.K. and Clas, S.D., “Evaluation of disintegration testing of different fast dissolving tablets using the texture analyzer,”Pharm. Dev. Technol. 7:361-371, Marcel Dekker, Inc. (2002).
Habib, W., et al., “Fast-dissolve drug delivery systems,”Critical Reviews™ in Therapeutic Drug Carrier Systems 17:61-72, Begell House, Inc. (2000).
Ishikawa, T., et al., “Preparation of rapidly disintegrating tablet using new types of microcrystalline cellulose (PH-M Series) and low substituted-hydroxypropylcellulose or spherical sugar granules by direct compression method,”Chem. Pharm. Bull. 49:134-139, Pharmaceutical Society of Japan (2001).
Klancke, J. “Dissolution testing of orally disintegrating tablets,”Dissolution Tech. 10, Dissolution Technologies, Inc. (2003) Accessed online: http://www.dissolutiontech.com/DTresour/0503art/DT0503art1.pdf, last accessed Sep. 27, 2006.
Koizumi, K., et al., “New method of preparing high-porosity rapidly saliva soluble compressed tablets using mannitol with camphor, a subliming material,”Intl. J. Pharm. 152:127-131, Elsevier Science B.V. (1997).
Liang, A.C. and Chen, L.H., “Fast-dissolving intraoral drug delivery systems,”Expert Opinion on Therapeutic Patents 11:981-986, Ashley Publications Ltd. (2001).
Lowenthal, W., “Mechanism of action of tablet disintegrants,”Pharmaceutica Acta Helvetiae 48:589-609, Elsevier B.V. (1973).
Massimo, G., et al., “Disintegration propensity of tablets evaluated by means of disintegrating force kinetics,”Pharm. Dev. Technol. 5:163-169, Marcel Dekker, Inc. (2000).
Ringard, J. and Gyuot-Hermann, A.M., “Calculation of disintegrant critical concentration in order to optimize tabl
Ahmed Salah U.
Chowdhury Tahseen A.
Li Lianli
Barr Laboratories, Inc.
Richter Johann R
Sterne Kessler Goldstein & Fox P.L.L.C.
Sullivan Danielle
LandOfFree
Non-effervescent, orally disintegrating solid pharmaceutical... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Non-effervescent, orally disintegrating solid pharmaceutical..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Non-effervescent, orally disintegrating solid pharmaceutical... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4194343